Showing results (3001-3010 of 13,185) with videos related to
Sort By:
Pageof 1,319
Diabetes Care|February 22, 2023
Physical Activity and Insulin Sensitivity Independently Attenuate the Effect of FTO rs9939609 on ObesityMette K Andersen, Lars Ängquist, Jette Bork-Jensen, et al.Diabetes Care|August 9, 2022
Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High RiskTonet Serés-Noriega, Marga Giménez, Verónica Perea, et al.Diabetes Care|August 9, 2022
The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With DiabetesKamlesh Khunti, Eva L Feldman, Neda Laiteerapong, et al.Diabetes Care|August 10, 2022
Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score AccuracyRebecca G Kim, Jasmine Deng, Jewel N Reaso, et al.Diabetes Care|March 17, 2023
Psychiatric Morbidity in Women With Previous Gestational Diabetes Mellitus: A Nationwide Register-Based Cohort StudyMaria Hornstrup Christensen, Marianne Skovsager Andersen, Katrine Hass Rubin, et al.Diabetes Care|March 21, 2023
Once-Weekly Basal Insulin Fc Demonstrated Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With Type 2 Diabetes: A Phase 2 Randomized Control TrialJuliana M Bue-Valleskey, Christof M Kazda, Chenchen Ma, et al.Diabetes Care|March 2, 2023
Impact of Overnight Glucose on Next-Day Functioning in Adults With Type 1 Diabetes: An Exploratory Intensive Longitudinal StudyElizabeth A Pyatak, Donna Spruijt-Metz, Stefan Schneider, et al.Diabetes Care|March 15, 2023
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled TrialWilliam E Russell, Brian N Bundy, Mark S Anderson, et al.Diabetes Care|March 17, 2023
CRP, C-Peptide, and Risk of First-Time Cardiovascular Events and Mortality in Early Type 2 Diabetes: A Danish Cohort StudyAnne Gedebjerg, Mette Bjerre, Alisa Devedzic Kjaergaard, et al.Diabetes Care|January 1, 1986
Metabolic control may alter antithrombin III activity but not its plasma concentration in diabetes: a possible role for nonenzymatic glycosylationA Ceriello, D Giugliano, P Dello Russo, et al.Pageof 1,319